APA (7th ed.) Citation

A, D., LA, M., AC, A., CE, S., R, H., CC, C., . . . KH, M. (2015). A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine. Mucosal immunology, 8(3), 607. https://doi.org/10.1038/mi.2014.93

Chicago Style (17th ed.) Citation

A, Dunne, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, and Mills KH. "A Novel TLR2 Agonist from Bordetella Pertussis Is a Potent Adjuvant That Promotes Protective Immunity with an Acellular Pertussis Vaccine." Mucosal Immunology 8, no. 3 (2015): 607. https://doi.org/10.1038/mi.2014.93.

MLA (9th ed.) Citation

A, Dunne, et al. "A Novel TLR2 Agonist from Bordetella Pertussis Is a Potent Adjuvant That Promotes Protective Immunity with an Acellular Pertussis Vaccine." Mucosal Immunology, vol. 8, no. 3, 2015, p. 607, https://doi.org/10.1038/mi.2014.93.